Raras
Buscar doenças, sintomas, genes...
Retinosquise ligada ao X
ORPHA:792CID-10 · Q14.1CID-11 · 9B73.11OMIM 312700DOENÇA RARA

Uma doença genética dos olhos que causa baixa visão em homens, devido a uma degeneração macular que se inicia na juventude.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Uma doença genética dos olhos que causa baixa visão em homens, devido a uma degeneração macular que se inicia na juventude.

Pesquisas ativas
6 ensaios
12 total registrados no ClinicalTrials.gov
Publicações científicas
528 artigos
Último publicado: 2026 Apr 6

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
1-9 / 100 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
5.0
Denmark
Início
Adolescent
+ adult, childhood, infancy
🏥
SUS: Cobertura mínimaScore: 15%
CID-10: Q14.1
🇧🇷Dados SUS / DATASUS
PROCEDIMENTOS SIGTAP (5)
0202010503
Cariótipo — bandas G, Q ou Rgenetic_test
0202010600
Pesquisa de microdeleções/microduplicações por FISHlab_test
0202010694
Sequenciamento completo do exoma (WES)rehabilitation
0202010260
Dosagem de alfa-fetoproteína
0301070040
Atendimento em reabilitação — doenças raras
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Características mais comuns

100%prev.
Fenômeno de Mizuo
Ocasional (29-5%)
90%prev.
Perda visual progressiva
Muito frequente (99-80%)
90%prev.
Glaucoma
Muito frequente (99-80%)
90%prev.
Anormalidade da visão
Muito frequente (99-80%)
90%prev.
Anormalidade do movimento ocular
Muito frequente (99-80%)
90%prev.
Eletroretinograma anormal
Muito frequente (99-80%)
22sintomas
Muito frequente (7)
Frequente (7)
Ocasional (3)
Sem dados (5)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 22 características clínicas mais associadas, ordenadas por frequência.

Fenômeno de MizuoMizuo phenomenon
Ocasional (29-5%)100%
Perda visual progressivaProgressive visual loss
Muito frequente (99-80%)90%
Glaucoma
Muito frequente (99-80%)90%
Anormalidade da visãoAbnormality of vision
Muito frequente (99-80%)90%
Anormalidade do movimento ocularAbnormality of eye movement
Muito frequente (99-80%)90%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico528PubMed
Últimos 10 anos200publicações
Pico202543 papers
Linha do tempo
2026Hoje · 2026🧪 2003Primeiro ensaio clínico📈 2025Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

2 genes identificados com associação a esta condição. Padrão de herança: X-linked recessive.

RS1RetinoschisinDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Binds negatively charged membrane lipids, such as phosphatidylserine and phosphoinositides (By similarity). May play a role in cell-cell adhesion processes in the retina, via homomeric interaction between octamers present on the surface of two neighboring cells (PubMed:27114531). Required for normal structure and function of the retina (PubMed:19093009)

LOCALIZAÇÃO

SecretedCell membrane

MECANISMO DE DOENÇA

Retinoschisis juvenile X-linked 1

A vitreo-retinal dystrophy characterized by macular pathology and by splitting of the superficial layer of the retina. Macular changes are present in almost all cases. In the fundi, radially oriented intraretinal foveomacular cysts are seen in a spoke-wheel configuration, with the absence of foveal reflex in most cases. In addition, approximately half of cases have bilateral peripheral retinoschisis in the inferotemporal part of the retina. Aside from the typical fundus appearance, strabismus, nystagmus, axial hyperopia, defective color vision and foveal ectopy can be present. The most important complications are vitreous hemorrhage, retinal detachment, and neovascular glaucoma.

EXPRESSÃO TECIDUAL(Baixa expressão)
Pulmão
2.2 TPM
Brain Frontal Cortex BA9
1.4 TPM
Córtex cerebral
1.2 TPM
Brain Anterior cingulate cortex BA24
1.0 TPM
Brain Caudate basal ganglia
1.0 TPM
INTERAÇÕES PROTEICAS (2)
OUTRAS DOENÇAS (1)
X-linked retinoschisis
HGNC:10457UniProt:O15537
CDKL5Cyclin-dependent kinase-like 5Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Mediates phosphorylation of MECP2 (PubMed:15917271, PubMed:16935860). May regulate ciliogenesis (PubMed:29420175)

LOCALIZAÇÃO

NucleusCytoplasm, cytoskeleton, cilium basal bodyCytoplasm, cytoskeleton, microtubule organizing center, centrosome

OUTRAS DOENÇAS (5)
developmental and epileptic encephalopathy, 2X-linked retinoschisisCDKL5 disorderearly-infantile DEE
HGNC:11411UniProt:O76039

Variantes genéticas (ClinVar)

2,554 variantes patogênicas registradas no ClinVar.

🧬 CDKL5: GRCh38/hg38 Xp22.33-11.4(chrX:251888-42476276)x2 ()
🧬 CDKL5: NM_001323289.2(CDKL5):c.401G>A (p.Arg134Gln) ()
🧬 CDKL5: NM_001323289.2(CDKL5):c.2231G>A (p.Ser744Asn) ()
🧬 CDKL5: NM_001323289.2(CDKL5):c.1995A>G (p.Lys665=) ()
🧬 CDKL5: NM_001323289.2(CDKL5):c.1326G>A (p.Gln442=) ()
Ver todas no ClinVar

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
2Fase 24
1Fase 13
·Pré-clínico5
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 12 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Retinosquise ligada ao X

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

4 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

12 ensaios clínicos encontrados, 6 ativos.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

🥈Melhor nível de evidência: Observacional
Timeline de publicações
312 papers (10 anos)
#1

Laterally spreading AAV.SPR enables safe and efficient RS1 delivery to the macula after peripheral subretinal injection.

Molecular therapy : the journal of the American Society of Gene Therapy2026 Mar 11

Mutations in RS1 are associated with X-linked retinoschisis (XLRS), a common cause of juvenile macular degeneration in males. Schisis cavities in the central retina of these patients have hampered submacular delivery with conventional adeno-associated viruses (AAVs). Clinical trials employing intravitreally injected AAVs showed a lack of efficacy and inflammation. Here, we demonstrate, in non-human primate (NHP) retina, that AAV.SPR, a laterally spreading capsid, transduced photoreceptors in the macula/fovea without the need for central retinal detachment, enabling transgene expression multiple millimeters beyond the subretinal injection (SRI) bleb margins. Peripheral SRI of AAV.SPR-hGRK1-RS1 resulted in robust and properly localized RS1 expression in NHP fovea. Despite being a secreted protein, biodistribution of RS1 remains confined to the area of AAV-RS1 transduction. Having established feasibility for the approach, we performed preclinical proof-of-concept, safety, and efficacy studies in support of "ATSN-201" (NCT05878860). In RS1KO mice, a "hybrid" efficacy/safety study demonstrated dose-dependent improvements in retinal function and structure and proper localization of RS1 following treatment with ATSN-201. A good laboratory practice (GLP) toxicology study in NHPs established safety at the highest dose evaluated. The enhanced transduction and lateral spreading ability of AAV.SPR make it an attractive option for treating inherited retinal diseases including, but not limited to, XLRS.

#2

Advanced therapeutic approaches for inherited retinal diseases: an umbrella review.

BMJ open2026 Feb 27

To evaluate the efficacy and safety of advanced therapeutic approaches for inherited retinal disease (IRD) using evidence from systematic reviews and meta-analyses. Umbrella review. We searched for Epistemonikos, PubMed, Scopus, PsycInfo, Google Scholar, Joanna Briggs Institute Evidence Synthesis, the Cochrane Database of Systematic Reviews and Database of Abstracts of Reviews of Effects from inception to November 2024. This included English-language systematic review and meta-analysis assessing advanced therapies in patients with IRD (including congenital retinal dystrophies, retinal dystrophies, retinitis pigmentosa (RP), Stargardt disease, X linked RP, achromatopsia, cone-rod dystrophy, choroideraemia and X linked retinoschisis). Reviews that did not meet the methodological quality threshold were excluded. Two reviewers independently screened and extracted the data, with disagreements resolved by consensus. Findings were synthesised narratively due to the substantial overlap of primary studies. Six systematic reviews and meta-analyses published from 2020 onwards were included, comprising between 6 and 21 primary studies per review. The therapies evaluated included gene therapy, cell-based therapy and stem cell-based interventions. Reported effect estimates showed modest to clinically meaningful improvements in best-corrected visual acuity and retinal structural outcomes in selected IRD subtypes, although effect sizes varied widely across interventions and conditions. The GRADE certainty of evidence ranged from moderate to low, reflecting bias, imprecision and heterogeneity risks. Substantial overlap of primary studies was observed (corrected covered area = 28.9%), precluding quantitative pooling across reviews. The findings suggest notable improvements in visual acuity, retinal structure and other critical outcomes, with therapies such as cell therapy, gene therapy and stem cell therapy showing promising results in enhancing treatment efficacy. Although there are examples of successes with supportive evidence, the overall evidence is not sufficiently strong to make general recommendations, as studies still need to be evaluated on a case-by-case basis. Further high-quality, large-scale randomised controlled trials are needed to better confirm their efficacy and safety.

#3

Profound Effect of Light on Cysts in X-Linked Retinoschisis.

Investigative ophthalmology &amp; visual science2026 Feb 02

X-linked retinoschisis (XLRS), caused by RS1 pathogenic variants, leads to macular dystrophy. Patients with XLRS show diurnal changes in optical coherence tomography (OCT), with more schisis in the morning. We studied diurnal variation in Rs1-knockout (KO) mice retinal structure and electrical function. Rs1-KO mice 2.5 to 4 months old (MO) had electroretinogram (ERG), OCT, and intraocular pressure (IOP) measurements collected at 5 AM and 5 PM on different days and under different experimental conditions. Mice were maintained under standard 12-hour light/dark cycle, reversed 12-hour light/dark cycle, continuous light, or continuous darkness. At study endpoint, eyes were collected and fixed for immunohistochemistry or harvested for Western blot analysis. Extended light exposure resolved cysts completely and improved ERG b-wave amplitudes, whereas darkness worsened schisis and ERG function. Synaptic staining confirmed disrupted photoreceptor-bipolar connections in dark-exposed retinas and reorganization after light exposure, without changes in synaptic protein expression or rhodopsin localization. IOP still followed a diurnal pattern under constant light or dark, whereas cyst fluctuation correlated with lighting rather than time of day. Initial findings suggested a diurnal rhythm in cyst size but reversed light cycle experiments showed that light exposure-not time of day-drives retinal changes in Rs1-KO mice. RS1-deficient retinas are vulnerable to darkness, whereas light exposure preserves retinal structure and function. To ensure valid OCT and ERG comparisons in XLRS, measurements should be time- and lighting-stamped. Dark-adapted conditions may best reveal treatment effects. Controlled light exposure may be a therapeutic option for patients with XLRS.

#4

Microglial phagocytosis of bipolar cells triggers inner retinal degeneration in Rs1-KO mice.

Cell communication and signaling : CCS2026 Jan 28

X-linked juvenile retinoschisis (XLRS) is a hereditary retinal disorder caused by mutations in the RS1 gene that leads to the formation of cavities in the inner nuclear layer (INL) and progressive vision loss, characterized by a disproportionate reduction of the b-wave compared to the a-wave in electroretinography (ERG). While previous research has largely focused on photoreceptor degeneration in XLRS, the specific roles of other cell populations, particularly bipolar cells and microglia, in the early stages of the disease have remained less well understood. Thus, this study aimed to elucidate the early cellular and molecular mechanisms of retinal degeneration in XLRS, with a particular focus on the role of microglia and bipolar cells. Retinal structure and function were assessed in CRISPR/Cas9 Rs1-exon2 knockout (Rs1−/y) mice at 8 and 24 weeks using histology, spectral-domain optical coherence tomography (SD-OCT), ERG, and optokinetic response. To analyze cell-specific changes, we performed TUNEL assay, immunofluorescence, flow cytometry, and single-cell RNA sequencing (scRNA-seq) with trajectory analysis. Rs1−/y mice successfully recapitulated classic XLRS features, including INL schisis, reduced b/a-wave ERG ratio, and early vision loss. TUNEL assay and histological analysis revealed that cell death initiated in the INL at 8 weeks and progressed to the outer nuclear layer (ONL), while microglia displayed a progressive transition from a ramified to an ameboid morphology. scRNA-seq demonstrated a significant loss of cone bipolar cells, especially OFF-cone subtypes, which preceded photoreceptor degeneration. Importantly, microglial activation and enhanced phagocytosis of OFF-cone bipolar cells were observed prior to photoreceptor loss. This phagocytic process was found to be mediated by phosphatidylserine and complement C3b, independent of caspase-3 pathways. Our findings demonstrate that bipolar cell degeneration, driven by microglial phagocytosis of stressed yet viable OFF-cone bipolar cells, is an early and critical pathological event in XLRS that precedes photoreceptor loss. This process involves "eat-me" signals and complement activation independent of classical apoptosis. These results provide a new perspective on XLRS pathogenesis and suggest that therapeutic strategies targeting bipolar cells and microglial activity could offer promising avenues for early intervention. The online version contains supplementary material available at 10.1186/s12964-026-02692-8.

#5

Progression in X-Linked Retinoschisis: A Longitudinal Study Defining Quantitative Biomarkers and Their Implications for Gene Therapy.

American journal of ophthalmology2026 Feb 26

To delineate age-related changes in visual, structural, and electrophysiologic measures in X-linked retinoschisis (XLRS) and to assess automated cyst-cavity volume (CCV) as a quantitative biomarker. Single-center mixed retrospective-prospective cohort study. This study included 440 visits from 107 individuals with clinically diagnosed XLRS and confirmed pathogenic RS1 variants. Comprehensive ophthalmic evaluations were performed at baseline and during follow-up, including visual acuity (VA), fundus examination, electroretinogram (ERG), and spectral-domain optical coherence tomography (SD-OCT), with microperimetry (MP) conducted in a subset of patients. Among SD-OCT parameters, CCV was automatically quantified using self-developed DEEP-OCT-CCSEG system. Annual progression rates were estimated using restricted cubic spline or linear regression models, and interocular agreement was evaluated with Bland-Altman and intraclass correlation analyses. In this cohort, 70% patients presented by age 10. The median age at first examination was 7.3 years (range, 1.9-78.5) over a mean follow-up of 1.9 years. Baseline means were: VA 0.82 ± 0.47 logMAR, central foveal thickness (CFT) 495 ± 186 µm, and CCV 1.54 ± 1.16 mm³. Genetic analysis identified 64 distinct RS1 variants, including 5 that were novel. Longitudinally, visual acuity followed a triphasic pattern: slight improvement in childhood, a prolonged plateau through mid-adulthood, and a more rapid decline thereafter, with Kaplan-Meier analysis projecting 40% of patients will be blind by age 60. Scotopic ERG a- and b-wave amplitudes peaked in early childhood before declining with age, while the b/a ratio gradually decreased. In OCT, CFT showed a modest, significant age-related decrease. In contrast, CCV followed a non-linear age-related pattern, increasing to a peak in the third decade of life before progressively declining. In this XLRS cohort, most patients showed gradual structural and functional decline beginning in the second decade of life, suggesting an optimal therapeutic window within early adulthood. By applying CCV as a quantitative biomarker in a large-scale longitudinal setting for the first time, this study quantitatively characterized 3-dimensional retinal remodeling and delineated age-related structural changes in XLRS. These findings refine the understanding of XLRS natural history and provide a robust framework for therapeutic evaluation and clinical trial design.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC345 artigos no totalmostrando 197

2026

Comprehensive analysis of RS1 gene mutations and clinical manifestations in nine unrelated X-linked retinoschisis (XLRS) Chinese families.

BMC ophthalmology
2026

Laterally spreading AAV.SPR enables safe and efficient RS1 delivery to the macula after peripheral subretinal injection.

Molecular therapy : the journal of the American Society of Gene Therapy
2026

Advanced therapeutic approaches for inherited retinal diseases: an umbrella review.

BMJ open
2026

Progression in X-Linked Retinoschisis: A Longitudinal Study Defining Quantitative Biomarkers and Their Implications for Gene Therapy.

American journal of ophthalmology
2026

Bullous Peripheral Retinoschisis: Structural Biomarker for Complications in X-Linked Retinoschisis via Ultrawide-Field Swept Source Optical Coherence Tomography.

American journal of ophthalmology
2026

Profound Effect of Light on Cysts in X-Linked Retinoschisis.

Investigative ophthalmology &amp; visual science
2025

Case Report: Preventing X-linked retinoschisis transmission via MARSALA-based PGT-M.

Frontiers in ophthalmology
2026

Microglial phagocytosis of bipolar cells triggers inner retinal degeneration in Rs1-KO mice.

Cell communication and signaling : CCS
2025

Presumed X-Linked Retinoschisis in a 3-Month-Old Baby Girl: A Case Report.

Case reports in ophthalmological medicine
2025

Vitreoretinal complications and surgical outcomes in patients with X-linked retinoschisis.

Acta ophthalmologica
2025

Clinical characteristics and management outcomes of pediatric full-thickness macular holes.

Canadian journal of ophthalmology. Journal canadien d'ophtalmologie
2025

OCT Angiography in X-Linked Retinoschisis.

JAMA ophthalmology
2025

Case Report: Carbonic anhydrase inhibitor brinzolamide dramatically improved the morphology and also function of a patient with RS1 mutation.

Frontiers in pharmacology
2025

Cystoid Macular Lesions in Inherited Retinal Diseases: Prevalence, Characteristics, and Genetic Associations in a Hungarian Cohort.

Genes
2025

Case series: Transient neonatal macular retinoschisis - a developmental phenomenon in term infants.

Eye (London, England)
2025

Molecular analysis of foveoschisis in females reveals a novel case of segmental uniparental disomy in X-linked retinoschisis.

Documenta ophthalmologica. Advances in ophthalmology
2025

Non-Neoplastic Disorders Mimicking Posterior Segment Inflammation.

Ocular immunology and inflammation
2025

Dual delivery of supramolecular nanoparticle-carried minicircle donor DNA with Cas9/gRNA improved HITI knock-in efficiency in X-linked juvenile retinoschisis.

International journal of biological macromolecules
2025

Transient Resolution of Foveal Schisis Following Macula-Involving Retinal Detachment in Juvenile X-Linked Retinoschisis.

Case reports in ophthalmological medicine
2025

One down but many more to go: the state of gene therapy for inherited retinal disease.

Regenerative medicine
2025

Long-term results of conservative and surgical treatment of congenital x-linked retinoschisis: A retrospective multicentre international study.

Acta ophthalmologica
2025

Coats-Like Response in X-Linked Retinoschisis.

Ophthalmology. Retina
2025

---Pars plana vitrectomy in congenital X-linked retinoschisis: a scoping review.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
2025

Retinal detachment associated with the splice site mutation c.53-1G>A in the RS1 gene: A case report and review of the literature.

SAGE open medical case reports
2025

Progression of Dark-Adapted Visual Fields Over 3 Years in the Rate of Progression in USH2A-Related Retinal Degeneration (RUSH2A) Study.

Investigative ophthalmology &amp; visual science
2025

Immune landscape in children with X-linked retinoschisis.

BMC immunology
2025

Advances in Precision Therapeutics and Gene Therapy Applications for Retinal Diseases: Impact and Future Directions.

Genes
2025

Dark Rearing Does Not Alter Developmental Retinoschisis Cavity Formation in Rs1 Gene Knockout Rat Model of X-Linked Retinoschisis.

Genes
2026

Spontaneous Resolution of Bullous X-Linked Retinoschisis.

Ophthalmology. Retina
2025

A novel deletion-insertion variant of RS1 in X-linked retinoschisis.

Ophthalmic genetics
2025

Characterisation and prevalence of inherited retinal diseases in the Finnish population reveals enrichment of population-specific phenotypes and causative variants.

The British journal of ophthalmology
2026

Bilateral Macular Ectopia and Folds in X-Linked Retinoschisis.

Ophthalmology. Retina
2025

Understanding the phenotype of genetically associated electronegative ERG retinopathies: comparing the full-field ERG b:a ratio.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
2025

Functional Vision Assessment Over 4 Years in USH2A Using the Veteran Affairs Low-Vision Visual Functioning Questionnaire.

Investigative ophthalmology &amp; visual science
2025

Multimodal Imaging of a Patient With X-Linked Retinoschisis and Bilateral Coats-Like Vasculopathy.

Retina (Philadelphia, Pa.)
2025

New OCT sign in X-linked retinoschisis without macular schisis: "Inverted roof fovea".

Archivos de la Sociedad Espanola de Oftalmologia
2025

A case of bilateral stellate nonhereditary idiopathic foveomacular retinoschisis with 14-month follow-up: clinical features, OCT findings and treatment outcome.

BMC ophthalmology
2025

[Clinical characteristics of the vascular changes in pediatric patients with congenital retinoschisis].

[Zhonghua yan ke za zhi] Chinese journal of ophthalmology
2025

AI image analysis tools quantify schisis cystic volume in XLRS retinal dysmorphology.

Acta ophthalmologica
2025

Deep learning model for detecting cystoid fluid collections on optical coherence tomography in X-linked retinoschisis patients.

Acta ophthalmologica
2025

Comparison of retinal structure and schisis location in X-linked retinoschisis and enhanced S-cone syndrome.

Retina (Philadelphia, Pa.)
2025

Artificial intelligence-quantified schisis volume as a structural endpoint for gene therapy clinical trials in X-linked retinoschisis.

Acta ophthalmologica
2025

Angle closure glaucoma in a patient with X-linked retinoschisis: a case report.

International journal of ophthalmology
2025

Disparate X-linked retinoschisis phenotypes in fraternal twins with the same pathogenic variant in the RS1 gene.

Ophthalmic genetics
2025

Congenital X-Linked Retinoschisis in an Indian Population: A Single Center Study in 70 Eyes.

American journal of ophthalmology
2025

Frequency and Pattern of Gene Therapy Clinical Trials for Inherited Retinal Diseases.

Advances in experimental medicine and biology
2025

Generation of human induced pluripotent stem cell lines from three different male XLRS patients carrying RS1 gene mutation.

Stem cell research
2025

Advancing Insights into Pediatric Macular Diseases: A Comprehensive Review.

Journal of clinical medicine
2024

Kir4.1 and Aqp4 Contribution to Schisis Cystic Water Accumulation and Clearance in the Rs1 Exon-1 Del XLRS Rat Model.

Genes
2024

The Evaluation of Ocular Posterior Segment Findings in 5527 Term Infants Using Smartphone-Based Fundus Imaging.

Journal of ophthalmology
2025

Review: Clinical findings and genetic characterization of children affected with X-linked retinoschisis in the Spanish population.

European journal of ophthalmology
2025

Identifying Multiomic Signatures of X-Linked Retinoschisis-Derived Retinal Organoids and Mice Harboring Patient-Specific Mutation Using Spatiotemporal Single-Cell Transcriptomics.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)
2024

An osmolarity dependent mechanism partially ameliorates retinal cysts and rescues cone function in a mouse model of X-linked retinoschisis.

Frontiers in medicine
2025

A retrospective longitudinal study of 52 Finnish patients with X-linked retinoschisis.

Acta ophthalmologica
2024

Endpoints and Design for Clinical Trials in USH2A-Related Retinal Degeneration: Results and Recommendations From the RUSH2A Natural History Study.

Translational vision science &amp; technology
2024

Family of juvenile X-linked retinoschisis with varied presentation: a case series with RS1 genetic analysis.

Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus
2025

Genotype-Phenotype Correlations in 83 Korean X-linked Retinoschisis Patients: Impact of Retinoschisin 1 Secretion Profiles on Clinical Phenotypes.

Ophthalmology. Retina
2024

Introduction of an RS1 mutation causative variant consistent with identified XLRS patient using CRISPR/Cas9 technology in normal iPSC.

Stem cell research
2024

Peripapillary retinal nerve fibre layer thinning in patients with X-linked retinoschisis.

BMJ open ophthalmology
2024

Frequency and Genetic Spectrum of Inherited Retinal Dystrophies in a Large Dutch Pediatric Cohort: The RD5000 Consortium.

Investigative ophthalmology &amp; visual science
2024

Investigating the role of Caspase-1 in a mouse model of Juvenile X-linked Retinoschisis.

Frontiers in medicine
2024

Self-Reported Functional Vision in USH2A-Associated Retinal Degeneration as Measured by the Michigan Retinal Degeneration Questionnaire.

Investigative ophthalmology &amp; visual science
2024

Retinal organoids with X-linked retinoschisis RS1 (E72K) mutation exhibit a photoreceptor developmental delay and are rescued by gene augmentation therapy.

Stem cell research &amp; therapy
2024

Choroidal neovascularisation secondary toX-linked retinoschisis.

The British journal of ophthalmology
2024

Intravitreal Delivery of rAAV2-hSyn-hRS1 Results in Retinal Ganglion Cell-Specific Gene Expression and Retinal Improvement in the Rs1-KO Mouse.

Human gene therapy
2024

Nationwide epidemiologic survey on incidence of macular dystrophy in Japan.

Japanese journal of ophthalmology
2024

Photoreceptor deficits appear at eye opening in Rs1 mutant mouse models of X-linked retinoschisis.

Experimental eye research
2024

Drug interactions of carbonic anhydrase inhibitors and activators.

Expert opinion on drug metabolism &amp; toxicology
2024

The dose-response relationship of subretinal gene therapy with rAAV2tYF-CB-hRS1 in a mouse model of X-linked retinoschisis.

Frontiers in medicine
2024

Early recurrence of macular schisis in X-linked retinoschisis treated with vitrectomy for rhegmatogenous retinal detachment under silicone oil: case report and brief literature review.

Therapeutic advances in ophthalmology
2023

Morphological and functional parameters in X-linked retinoschisis patients-A multicentre retrospective cohort study.

Frontiers in medicine
2024

Intravitreal injection of new adeno-associated viral vector: Enhancing retinoschisin 1 gene transduction in a mouse model of X-linked retinoschisis.

Biochemistry and biophysics reports
2024

Genotype-Phenotype Associations in an X-Linked Retinoschisis Patient Cohort: The Molecular Dynamic Insight and a Promising SD-OCT Indicator.

Investigative ophthalmology &amp; visual science
2024

Genotypic and phenotypic diversity in X-linked retinoschisis: Findings from a South Indian patient cohort.

Indian journal of ophthalmology
2024

Phenotyping and genotyping inherited retinal diseases: Molecular genetics, clinical and imaging features, and therapeutics of macular dystrophies, cone and cone-rod dystrophies, rod-cone dystrophies, Leber congenital amaurosis, and cone dysfunction syndromes.

Progress in retinal and eye research
2024

Optical coherence tomography in children with inherited retinal disease.

Clinical &amp; experimental optometry
2023

A visually guided swim assay for mouse models of human retinal disease recapitulates the multi-luminance mobility test in humans.

Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society
2023

A Literary Pediatric Retina Fellowship With Michael T. Trese, MD.

Ophthalmic surgery, lasers &amp; imaging retina
2024

Efficacy of Carbonic Anhydrase Inhibitors on Cystoid Fluid Collections and Visual Acuity in Patients with X-Linked Retinoschisis.

Ophthalmology. Retina
2023

Visual Acuity-Related Outer Retinal Structural Parameters on Swept Source Optical Coherence Tomography and Angiography in XLRS Patients and Carriers.

Translational vision science &amp; technology
2023

Optical coherence tomography findings of the peripheral retina in patients with congenital X-linked retinoschisis.

Frontiers in medicine
2023

Carbonic anhydrase inhibitors limit complications in X-linked retinoschisis.

Frontiers in medicine
2023

Generation of a gene-corrected isogenic iPSC cell line from an X-linked retinoschisis patient with a hemizygous mutation c.304C > T (p.R102W) in RS1 gene.

Stem cell research
2023

Safety and Efficacy of Adeno-Associated Viral Gene Therapy in Patients With Retinal Degeneration: A Systematic Review and Meta-Analysis.

Translational vision science &amp; technology
2023

AN EIGHT-YEAR RETROSPECTIVE STUDY OF THE ETIOLOGIES, CLINICAL CHARACTERISTICS, AND VISUAL OUTCOMES OF PEDIATRIC LAMELLAR MACULAR HOLE.

Retina (Philadelphia, Pa.)
2023

Concurrent Foveoschisis and Atrophy in a Patient With X-Linked Retinoschisis and Type 1 Diabetes Mellitus.

Ophthalmic surgery, lasers &amp; imaging retina
2023

Retinal Detachments in Pediatric Patients With X-Linked Retinoschisis: Characteristics and Surgical Outcomes.

Ophthalmic surgery, lasers &amp; imaging retina
2023

The Value of Electroretinography in Identifying Candidate Genes for Inherited Retinal Dystrophies: A Diagnostic Guide.

Diagnostics (Basel, Switzerland)
2023

Bilateral Stellate Nonhereditary Idiopathic Foveomacular Retinoschisis (SNIFR) Incidentally Identified in a Non-Myopic Female.

Cureus
2023

Vitreous Hemorrhage in Pediatric Patients With X-Linked Retinoschisis: Characteristics and Outcomes.

Ophthalmic surgery, lasers &amp; imaging retina
2023

Case report: Familial foveal retinoschisis caused by CRB1 gene mutation in a family with recessive inheritance.

Frontiers in medicine
2023

Coats-like Vasculopathy in Inherited Retinal Disease: Prevalence, Characteristics, Genetics, and Management.

Ophthalmology
2023

Long-term functional and structural outcomes in X-linked retinoschisis: implications for clinical trials.

Frontiers in medicine
2023

Pars Plana Vitrectomy in Inherited Retinal Diseases: A Comprehensive Review of the Literature.

Life (Basel, Switzerland)
2023

A Carrier Female Manifesting an Unusual X-Linked Retinoschisis Phenotype Associated with the Pathogenic Variant c.266delA, p.(Tyr89LeufsTer37) in RS1, and Skewed X-Inactivation.

Genes
2023

Identification and molecular characterization of two recurrent missense mutations in the RS1 gene in two families with X-linked retinoschisis from North India.

American journal of medical genetics. Part A
2023

X-Linked Retinoschisis Masquerading Uveitis.

Journal of clinical medicine
2023

Diurnal functional and anatomical changes in X-linked retinoschisis.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
2023

X-linked Retinoschisis with Near-Normal Macular Structure and Function.

Ophthalmology. Retina
2023

Vasoproliferative Tumor in X-Linked Retinoschisis.

Ophthalmology. Retina
2023

Acute angle-closure in juvenile X-linked retinoschisis.

Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus
2023

Management of angle-closure glaucoma with X-linked retinoschisis: a case report.

BMC ophthalmology
2023

A paradigm shift in the treatment of refractory angle closure glaucoma in a patient with X-linked juvenile retinoschisis.

Ophthalmic genetics
2023

Retinal honeycomb appearance and its role in patients with X-linked retinoschisis.

BMC ophthalmology
2023

Electrophysiological Evaluation of Macular Dystrophies.

Journal of clinical medicine
2023

Widefield Fluorescein Angiography Findings in Pediatric Patients with X-Linked Retinoschisis.

Ophthalmology. Retina
2023

Typical and atypical clinical presentations of X-Linked retinoschisis: A case series and literature review.

Survey of ophthalmology
2022

Posterior Segment Optical Coherence Tomography in Uncooperative Paediatric Patients Using Exo-Illumination and Microscope-Integrated Optical Coherence Tomography.

Cureus
2023

SYMPTOMATIC EARLY-ONSET X-LINKED RETINOSCHISIS: Clinical Presentation and Outcomes.

Retina (Philadelphia, Pa.)
2022

A patient with X-linked retinoschisis and exudative retinal detachment associated with a pathogenic hemizygous variant c.304c>T in RS1.

Ophthalmic genetics
2023

A Spontaneous Nonhuman Primate Model of Myopic Foveoschisis.

Investigative ophthalmology &amp; visual science
2023

Coral reef: optical coherence tomography angiography in X-linked retinoschisis.

Canadian journal of ophthalmology. Journal canadien d'ophtalmologie
2022

Specific Changes in OCT Imaging Associated with a Novel Mutation of the RS1 Gene in X-Linked Retinoschisis.

Klinische Monatsblatter fur Augenheilkunde
2022

AAV2/4-RS1 gene therapy in the retinoschisin knockout mouse model of X-linked retinoschisis.

PloS one
2022

Case report: Autosomal recessive bestrophinopathy with macular cysts and MNV over 13-year follow-up.

Frontiers in genetics
2023

Advances in understanding the molecular structure of retinoschisin while questions remain of biological function.

Progress in retinal and eye research
2022

Multimodal Retinal Imaging Findings in Two Cousins With VCAN-Related Vitreoretinopathy or Wagner Disease.

Ophthalmic surgery, lasers &amp; imaging retina
2023

X-linked retinoschisis: mutation spectrum and genotype-phenotype relationship in an Italian pediatric cohort.

Ophthalmic genetics
2022

XLRS Rat with Rs1-/Y Exon-1-Del Shows Failure of Early Postnatal Outer Retina Development.

Genes
2022

X-linked retinoschisis: About a case.

Archivos de la Sociedad Espanola de Oftalmologia
2023

X-linked retinoschisis: OCT-angiography in two brothers from a four-generation family with a p.Arg197Cys pathogenic variant in the RS1 gene.

European journal of ophthalmology
2022

Targeted Expression of Retinoschisin by Retinal Bipolar Cells in XLRS Promotes Resolution of Retinoschisis Cysts Sans RS1 From Photoreceptors.

Investigative ophthalmology &amp; visual science
2022

Retinal vasoproliferative tumor as first sign of X-linked retinoschisis in a 12-month-old boy.

Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus
2023

EFFICACY OF INNER WALL RETINECTOMY FOR BULLOUS SCHISIS CAVITY HANGING OVER OR THREATENING THE MACULA IN PATIENTS WITH CONGENITAL X-LINKED RETINOSCHISIS.

Retina (Philadelphia, Pa.)
2022

MACULAR MICROVASCULATURE IN X-LINKED RETINOSCHISIS: Optical Coherence Tomography and Optical Coherence Tomography Angiography Study.

Retina (Philadelphia, Pa.)
2022

Spatial and Temporal Integration Abnormalities in X-Linked Retinoschisis.

Investigative ophthalmology &amp; visual science
2022

TOPICAL CARBONIC ANHYDRASE INHIBITORS IN THE LONG-TERM TREATMENT OF JUVENILE X-LINKED RETINOSCHISIS.

Retina (Philadelphia, Pa.)
2022

Non-vasogenic cystoid maculopathies.

Progress in retinal and eye research
2022

Retinoschisin Deficiency Induces Persistent Aberrant Waves of Activity Affecting Neuroglial Signaling in the Retina.

The Journal of neuroscience : the official journal of the Society for Neuroscience
2022

Retinal Proteomic Alterations and Combined Transcriptomic-Proteomic Analysis in the Early Stages of Progression of a Mouse Model of X-Linked Retinoschisis.

Cells
2022

Longitudinal Photoreceptor Phenotype Observation and Therapeutic Evaluation of a Carbonic Anhydrase Inhibitor in a X-Linked Retinoschisis Mouse Model.

Frontiers in medicine
2022

Exudative maculopathy in presumed X-linked retinoschisis with review of literature.

Indian journal of ophthalmology
2022

Intravitreal Delivery of rAAV2tYF-CB-hRS1 Vector for Gene Augmentation Therapy in Patients with X-Linked Retinoschisis: 1-Year Clinical Results.

Ophthalmology. Retina
2022

An atypical early-onset X-linked retinoschisis mimicking uveitis masquerade syndrome.

Arquivos brasileiros de oftalmologia
2022

Retinal Folds as a Clinical Feature of X-Linked Retinoschisis: A Series of Three Cases.

Ophthalmic surgery, lasers &amp; imaging retina
2022

Mizuo-Nakamura phenomenon in X-linked retinoschisis.

American journal of ophthalmology case reports
2022

Predominant Founder Effect among Recurrent Pathogenic Variants for an X-Linked Disorder.

Genes
2022

[Analysis of RS1 gene variant in a Chinese pedigree affected with X-linked congenital retinal splitters].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2022

Contrast Sensitivity and Equivalent Intrinsic Noise in X-Linked Retinoschisis.

Translational vision science &amp; technology
2022

Vitreous hemorrhage in X-linked retinoschisis.

American journal of ophthalmology case reports
2021

Investigation of Correlations Between Optical Coherence Tomography Biomarkers and Visual Acuity in X-Linked Retinoschisis.

Frontiers in medicine
2022

Identification of Interphotoreceptor retinoid-binding protein in the Schisis cavity fluid of a patient with congenital X-linked Retinoschisis.

BMC ophthalmology
2022

The safety and efficacy of gene therapy treatment for monogenic retinal and optic nerve diseases: A systematic review.

Genetics in medicine : official journal of the American College of Medical Genetics
2022

Genotype and phenotype characteristics of X-linked retinoschisis: the first report of a Turkish population.

Ophthalmic genetics
2021

Clinical and Genetic Study of X-Linked Juvenile Retinoschisis in the Czech Population.

Genes
2022

X-Linked Retinoschisis: Deep Phenotyping and Genetic Characterization.

Ophthalmology
2022

Identification of a novel CRB1 variant in a compound heterozygous state in a patient with CRB1-associated maculopathy and foveal retinoschisis.

Ophthalmic genetics
2021

Gene Therapy in Inherited Retinal Diseases: An Update on Current State of the Art.

Frontiers in medicine
2021

Luminance Thresholds and Their Correlation With Retinal Structure in X-Linked Retinoschisis.

Investigative ophthalmology &amp; visual science
2021

Whole-exome sequencing identifies an RS1 variant in a Chinese family with X-linked retinoschisis.

Experimental and therapeutic medicine
2023

Clinical and genetic features of retinoschisis in 120 families with RS1 mutations.

The British journal of ophthalmology
2022

X-Linked Retinoschisis: Novel Clinical Observations and Genetic Spectrum in 340 Patients.

Ophthalmology
2020

X-Linked Retinoschisis and a Coats-Like Response in the Setting of Retinopathy of Prematurity.

Journal of vitreoretinal diseases
2021

X-linked Retinoschisis and Gene Therapy.

International ophthalmology clinics
2022

Rs1h-/y exon 3-del rat model of X-linked retinoschisis with early onset and rapid phenotype is rescued by RS1 supplementation.

Gene therapy
2021

Gene therapy for inherited retinal diseases.

Annals of translational medicine
2022

Of men and mice: Human X-linked retinoschisis and fidelity in mouse modeling.

Progress in retinal and eye research
2021

Spontaneous resolution of schitic cavities in XLRS.

Ophthalmic genetics
2021

High-speed and widefield handheld swept-source OCT angiography with a VCSEL light source.

Biomedical optics express
2021

Negative electroretinograms: genetic and acquired causes, diagnostic approaches and physiological insights.

Eye (London, England)
2021

CyberKnife Stereotactic Radiotherapy in Secondary Vasoproliferative Tumor of the Retina.

Case reports in ophthalmology
2020

Retinal imaging in inherited retinal diseases.

Annals of eye science
2021

Novel clinical presentation of a CRX rod-cone dystrophy.

BMJ case reports
2021

Molecular genetics of inherited retinal degenerations in Icelandic patients.

Clinical genetics
2021

Immune function in X-linked retinoschisis subjects in an AAV8-RS1 phase I/IIa gene therapy trial.

Molecular therapy : the journal of the American Society of Gene Therapy
2021

Engineered FnCas12a with enhanced activity through directional evolution in human cells.

The Journal of biological chemistry
2020

Clinical manifestation and genetic analysis in Chinese early onset X-linked retinoschisis.

Molecular genetics &amp; genomic medicine
2021

A novel mutation in the RS1 gene in a Chinese family with X-linked congenital retinoschisis.

Experimental and therapeutic medicine
2021

Current Clinical Applications of In Vivo Gene Therapy with AAVs.

Molecular therapy : the journal of the American Society of Gene Therapy
2020

Acute Vitreous and Intraretinal Hemorrhage with Multifocal Subretinal Fluid in Juvenile X-Linked Retinoschisis.

Case reports in ophthalmological medicine
2020

Retinal detachment repair with perfluoro-N-octane endotamponade in an infant with juvenile X-linked retinoschisis.

American journal of ophthalmology case reports
2021

Carbonic anhydrase inhibition in X-linked retinoschisis: An eye on the photoreceptors.

Experimental eye research
2021

Comprehensive analysis of genetic and clinical characteristics of 30 patients with X-linked juvenile retinoschisis in China.

Acta ophthalmologica
2020

Simplex Crumbs Homologue 1 Maculopathy Masquerading as Juvenile X-Linked Retinoschisis in Male Patients.

Journal of vitreoretinal diseases
2021

Genetic Rescue of X-Linked Retinoschisis Mouse (Rs1-/y) Retina Induces Quiescence of the Retinal Microglial Inflammatory State Following AAV8-RS1 Gene Transfer and Identifies Gene Networks Underlying Retinal Recovery.

Human gene therapy
2020

Effectiveness of Ripasudil, a Rho-Associated Coiled/Coil-Containing Protein Kinase Inhibitor, in Improving Retinoschisis and Cystic-Like Foveal Cavities in Eyes with X-Linked Retinoschisis.

Case reports in ophthalmology
2020

Surgical management of a large retinal cyst in X-linked retinoschisis with internal drainage: Report of an unusual case.

Indian journal of ophthalmology
2020

Multimodal imaging of bilateral macular hole in X-linked retinoschisis.

BMJ case reports
2020

A Female Case of X-Linked Retinoschisis with Macular Hole Bilaterally.

Case reports in ophthalmological medicine
2020

Electronegative Electroretinograms in the United Arab Emirates.

Middle East African journal of ophthalmology
2021

The X-linked retinopathies: Physiological insights, pathogenic mechanisms, phenotypic features and novel therapies.

Progress in retinal and eye research
2020

X-Linked Retinoschisis in Females in a Consanguineous Family: A Rare Entity.

Turkish journal of ophthalmology
2020

Retinoschisis associated with Kearns-Sayre syndrome.

Ophthalmic genetics
2021

A case of undiagnosed X-linked retinoschisis presenting as unilateral macular demarcation line.

European journal of ophthalmology
2020

X-Linked Retinoschisis without Macular Retinoschisis: A New RS1 Mutation.

Ophthalmology. Retina
2020

Dramatic response to topical dorzolamide in X-linked retinoschisis.

Indian journal of ophthalmology
2020

Full-Field Electroretinography, Pupillometry, and Luminance Thresholds in X-Linked Retinoschisis.

Investigative ophthalmology &amp; visual science
2020

Outcome measures in juvenile X-linked retinoschisis: A systematic review.

Eye (London, England)
2021

Unusual presentation of early-onset X-linked retinoschisis: Report after 1 year of multimodal follow-up.

European journal of ophthalmology
2020

Clinical findings and RS1 genotype in 90 Chinese families with X-linked retinoschisis.

Molecular vision
2020

Retinal Detachment in X-Linked Retinoschisis.

The New England journal of medicine
2020

CRB1-Related Cystic Maculopathy in Twins Conceived Through Heterologous Fertilization With Variant-Carrying Oocytes.

Journal of pediatric ophthalmology and strabismus
2020

X-linked peripheral retinoschisis without macular involvement: a case series with RS1 genetic confirmation.

Ophthalmic genetics
2020

Adult Presentation of X-Linked Retinoschisis: Patient and Physician Perspectives.

Ophthalmology and therapy
2020

Establishment of a human induced pluripotent stem cell line (CSUASOi005-A), from peripheral blood mononuclear cells of a patient with X-linked juvenile retinoschisis carrying a novel mutation in RS1 gene.

Stem cell research
2020

Peripheral retinal neovascularization secondary to highly myopic superficial Retinoschisis: a case report.

BMC ophthalmology
2020

Effect of light and diurnal variation on macular thickness in X-linked retinoschisis: a case series.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
Ver todos os 345 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Retinosquise ligada ao X.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Retinosquise ligada ao X

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Laterally spreading AAV.SPR enables safe and efficient RS1 delivery to the macula after peripheral subretinal injection.
    Molecular therapy : the journal of the American Society of Gene Therapy· 2026· PMID 41814654mais citado
  2. Advanced therapeutic approaches for inherited retinal diseases: an umbrella review.
    BMJ open· 2026· PMID 41760155mais citado
  3. Profound Effect of Light on Cysts in X-Linked Retinoschisis.
    Investigative ophthalmology &amp; visual science· 2026· PMID 41626874mais citado
  4. Microglial phagocytosis of bipolar cells triggers inner retinal degeneration in Rs1-KO mice.
    Cell communication and signaling : CCS· 2026· PMID 41593663mais citado
  5. Progression in X-Linked Retinoschisis: A Longitudinal Study Defining Quantitative Biomarkers and Their Implications for Gene Therapy.
    American journal of ophthalmology· 2026· PMID 41759649mais citado
  6. Upregulated TRPM1 is associated with apoptosis in Rs1 knockout mice and in ARPE19 cells through increased intracellular calcium.
    Sci Rep· 2026· PMID 41942595recente
  7. Comprehensive analysis of RS1 gene mutations and clinical manifestations in nine unrelated X-linked retinoschisis (XLRS) Chinese families.
    BMC Ophthalmol· 2026· PMID 41840530recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:792(Orphanet)
  2. OMIM OMIM:312700(OMIM)
  3. MONDO:0010725(MONDO)
  4. GARD:4690(GARD (NIH))
  5. Variantes catalogadas(ClinVar)
  6. Busca completa no PubMed(PubMed)
  7. Q3458131(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Retinosquise ligada ao X
Compêndio · Raras BR

Retinosquise ligada ao X

ORPHA:792 · MONDO:0010725
Prevalência
1-9 / 100 000
Herança
X-linked recessive
CID-10
Q14.1 · Malformação congênita da retina
CID-11
Ensaios
6 ativos
Início
Adolescent, Adult, Childhood, Infancy
Prevalência
5.0 (Denmark)
MedGen
UMLS
C0271091
EuropePMC
Wikidata
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades